ADIRAMEDICA HYOSCINE BUTYLBROMIDE 20 MG tablet blister pack
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
29-01-2020
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
hyoscine butylbromide, Quantity: 20 mg
Available from:
AdiraMedica Pty Ltd
Pharmaceutical form:
Tablet, film coated
Composition:
Excipient Ingredients: povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; lecithin
Administration route:
Oral
Units in package:
10
Prescription type:
(S2) Pharmacy Medicine
Therapeutic indications:
Spasm of the gastrointestinal tract
Product summary:
Visual Identification: White colored, round, biconvex, film coated tablet plain on both sides.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius
Authorization status:
Registered
Authorization date:
2019-12-11
